InsidersTradesSigma
Track the ネクセラファーマ株式会社 stock price and the full insider trade history of the company, a listed equity based in Japan. Shares are listed on JP JP, under the supervision of EDINET (Japan FSA). Market capitalisation: €84.6bn. The latest transaction was filed on 30 April 2026 (Holding update). Among the most active insiders: Gomi Daisuke. The full history is free.
Analysts rate ネクセラファーマ株式会社 Buy (bullish), based on 8 analysts. Average price target: JP¥1,838.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
11 of 11 declarations
Nexela Pharma Co., Ltd. is a company listed on the XTKS market, specializing in the pharmaceutical sector.